All lobbying filings

ACG Advocacy

ACG Advocacy filed a Q3 report for Abbvie on October 20, 2026, reporting $60,000 in lobbying income.

Lobbying for Abbvie · Biopharmaceutical company.

As filed: ACG ADVOCACY for ABBVIE.

All filings by ACG Advocacy · Everything Abbvie has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Lobbyists on this filing 4

CHRIS ISRAEL

Previously held: U.S. Coordinator for International IP Enforcement; Deputy Chief of Staff, Department of Commerce; Deputy Assistant Secretary for Tech Policy, Department of Commerce
CAMERON SEWARD

Previously held: Director, Integral Intergovernmental Affairs and Public Engagement - USTR
MANUS COONEY

Previously held: Staff Director & Chief Counsel, Senate Judiciary Committee
DANA COLARULLI

Previously held: Director, Government Affairs PTO

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Trade (domestic/foreign)

Trade Policy.

Patent Legislation. Patent Review Procedures.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.